10/17/2024
3:54 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 15-12G | |
10/04/2024
3:21 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:24 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:27 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:30 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:33 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:36 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
|
10/04/2024
3:18 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:16 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form POSASR | |
08/27/2024
9:14 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
08/13/2024
3:31 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/07/2024
3:51 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9/A | |
08/07/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/05/2024
7:14 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/01/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/31/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/30/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/29/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024
3:05 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities | |
07/18/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/18/2024
10:25 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024
3:20 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/05/2024
5:48 AM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9 | |
07/05/2024
5:02 AM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T | |
07/02/2024
9:18 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/21/2024
9:07 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024
3:41 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024
3:33 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC14D9C | |
06/20/2024
2:38 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-C | |
06/17/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024
11:06 AM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 13G/A | |
06/10/2024
10:01 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2024
3:36 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2024
9:22 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
Breaking News: Tesla headed to $500… (Ad) That headline hit late last night…and the rally has begun
Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.  So to claim your free digital copy today, simply follow this link and enter your email address. |
06/04/2024
9:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024
9:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024
9:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024
9:16 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024
9:13 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024
1:19 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9/A | |
05/23/2024
9:11 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024
8:04 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024
9:07 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/17/2024
9:15 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024
3:43 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9/A | |
05/16/2024
3:31 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/16/2024
9:11 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024
9:09 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024
9:27 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2024
9:19 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2024
9:31 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2024
9:08 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024
3:45 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/07/2024
9:24 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/06/2024
9:07 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/03/2024
9:29 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2024
3:31 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/02/2024
9:43 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024
9:07 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024
7:57 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024
3:15 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024
9:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/26/2024
9:11 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/25/2024
9:38 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024
10:03 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/23/2024
9:14 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024
9:32 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024
9:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024
3:31 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/18/2024
1:33 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D | |
04/18/2024
9:13 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/17/2024
3:49 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9/A | |
04/17/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/16/2024
4:07 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/16/2024
9:12 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024
2:44 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/12/2024
9:54 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024
10:57 AM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9 | |
04/11/2024
5:01 AM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T | |
04/09/2024
9:07 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
9:19 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024
9:15 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad) As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential.
Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! |
04/02/2024
9:08 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2024
12:16 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2024
10:15 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/25/2024
10:37 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/22/2024
10:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/22/2024
5:47 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/21/2024
10:27 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
3:12 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
10:13 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
